Retinopathy of prematurity.
Retinopathy of prematurity (ROP) is a rapidly evolving area of pediatric ophthalmology. Over the past decade, a new understanding of the pathophysiology of ROP has emerged. Advances in clinical research have lead to modifications in screening criteria and treatment guidelines for ROP. With this knowledge, new treatment modalities such as anti-angiogenic agents are being investigated. This review will highlight some of the current concepts related to ROP.
Sylvester
Christin L
CL
Children's Hospital of Pittsburgh, Division of Pediatric Ophthalmology, Pittsburgh, PA 15213, USA. sylvestercl@upmc.edu
D005136:Eye Proteins / Q000235:genetics; D006801:Humans; D007231:Infant, Newborn; D009154:Mutation; D009419:Nerve Tissue Proteins / Q000235:genetics; D017410:Practice Guidelines as Topic; D012178:Retinopathy of Prematurity / Q000175:diagnosis / Q000209:etiology / Q000503:physiopathology / Q000628:therapy; D012307:Risk Factors; D013285:Strabismus / Q000209:etiology; D017216:Telemedicine; D014786:Vision Disorders / Q000209:etiology
D005136:Eye Proteins; C081848:NDP protein, human; D009419:Nerve Tissue Proteins